BEMPEGALDESLEUKIN

UNII: BNO1JG5MZC
Preferred Substance Name: BEMPEGALDESLEUKIN

1939126-74-5
ALDESLEUKIN PRODRUG NKTR-214
BEMPEGALDESLEUKIN [INN]
BEMPEGALDESLEUKIN [USAN]
BEMPEGALDESLEUKIN [WHO-DD]
HOMO SAPIENS INTERLEUKIN-2 VARIANT(A1>DEL, C125>S) PRODUCED IN ESCHERICHIA COLI, IN WHICH AN AVERAGE OF 6 LYSINE RESIDUES ARE N6 SUBSTITUTED WITH ((2,7-BIS((.ALPHA.-METHYLPOLY(OXYETHYLENE))CARBAMOYL)-9H-FLUOREN-9-YL)METHOXY)CARBONYL
INTERLEUKIN 2 (DE-1-ALANINE,125-SERINE) (RECOMBINANT HUMAN), PEGYLATED
NKTR-214
NKTR-214 PRODRUG

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

About, Contact Us, Copyright, Privacy, Accessibility

U.S. Food and Drug Administration, 10903 New Hampshire Ave, Silver Spring, MD 20993-0002

U.S. Food and Drug Administration, Health & Human Services

Freedom of Information Act

BEMPEGALDESLEUKIN

Synonyms and Mappings

Resources

Note